Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy
BACKGROUND: Nephropathy is an important feature of classical Fabry disease, which results in alpha-galactosidase A deficiency and cellular globotriaosylceramide accumulation. We report the safety and efficacy of antiproteinuric therapy with ACE inhibitors or angiotensin II receptor blockers (ARBs) i...
Kaydedildi:
Yayımlandı: | J Med Genet |
---|---|
Asıl Yazarlar: | , , , , , , , , |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2015
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4717450/ https://ncbi.nlm.nih.gov/pubmed/26490103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmedgenet-2015-103471 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
Byddwch y cyntaf i adael sylw!